• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

(+)-WAY 100135,一种部分激动剂,作用于天然和重组5-HT1B/1D受体。

(+)-WAY 100135, a partial agonist, at native and recombinant 5-HT1B/1D receptors.

作者信息

Davidson C, Ho M, Price G W, Jones B J, Stamford J A

机构信息

Anaesthetics Unit (Neurotransmission Laboratory), St Bartholomew's and the Royal London School of Medicine and Dentistry, Royal London Hospital.

出版信息

Br J Pharmacol. 1997 Jun;121(4):737-42. doi: 10.1038/sj.bjp.0701197.

DOI:10.1038/sj.bjp.0701197
PMID:9208142
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1564750/
Abstract
  1. We have studied the effects of the purportedly selective 5-HT1A receptor antagonist (+)-WAY 100135 on electrically stimulated 5-hydroxytryptamine (5-HT) efflux in the ventrolateral geniculate nucleus (vLGN), and its affinity at human 5-HT1B and 5-HT1D receptors stably expressed in Chinese hamster ovary (CHO) cells. 2. On short 'pseudo single pulse' stimulations (20 pulses at 100 Hz, 190 ms train duration), (+)-WAY 100135 (1.0 microM) decreased 5-HT efflux in the vLGN to 68 +/- 8% of pre-drug values (P < 0.01). This decrease could be blocked by the 5-HT1D/1B receptor antagonist GR 127935 (50 nM). Conversely, when long stimulations (20 pulses at 20 Hz, 950 ms train) were used, (+)-WAY 100135 had no effect on 5-HT efflux (84 +/- 8% of pre-drug values) although both methiothepin (200 nM) and GR 127935 (50 nM) caused significant increases (to 175 +/- 18 and 130 +/- 10% of pre-drug values, respectively). 3. Paroxetine (100 nM), the selective 5-HT reuptake inhibitor, increased stimulated 5-HT efflux and reuptake half-life (to 145 +/- 18% and 649 +/- 121%, respectively) on pseudo single pulse stimulations. When (+)-WAY 100135 was added in combination with the uptake blocker, the effect of paroxetine on stimulated 5-HT efflux was potentiated to 282 +/- 48% (P < 0.01) without further effect on the 5-HT reuptake half-life. 4. The affinity and intrinsic activity of (+)-WAY 100135 were determined at recombinant human 5-HT1B and 5-HT1D receptors expressed in CHO cells, by use of radioligand binding and [35S]-GTP gamma S binding (+)-WAY 100135 was a partial agonist at human 5-HT1B and 5-HT1D receptors with moderately high affinity for 5-HT1D receptors (pEC50 = 7.61). 5. In conclusion, (+)-WAY 100135 was found to be not a selective 5-HT1A autoreceptor antagonist but may act as a partial agonist at the 5-HT1B/1D receptor, displaying agonist or antagonist properties depending on the stimulation protocol used and the resultant 5-HT 'tone' at the receptor.
摘要
  1. 我们研究了据称具有选择性的5-羟色胺1A(5-HT1A)受体拮抗剂(+)-WAY 100135对腹外侧膝状核(vLGN)中电刺激诱发的5-羟色胺(5-HT)外流的影响,以及它对稳定表达于中国仓鼠卵巢(CHO)细胞中的人5-HT1B和5-HT1D受体的亲和力。2. 在短时间的“伪单脉冲”刺激(100 Hz下20个脉冲,串长190 ms)时,(+)-WAY 100135(1.0 microM)使vLGN中的5-HT外流降至给药前值的68±8%(P<0.01)。这种降低可被5-HT1D/1B受体拮抗剂GR 127935(50 nM)阻断。相反,当使用长时间刺激(20 Hz下20个脉冲,串长950 ms)时,(+)-WAY 100135对5-HT外流无影响(为给药前值的84±8%),尽管甲硫哒嗪(200 nM)和GR 127935(50 nM)均引起显著增加(分别增至给药前值的175±18%和130±10%)。3. 选择性5-羟色胺再摄取抑制剂帕罗西汀(100 nM)在伪单脉冲刺激时增加了刺激诱发的5-HT外流和再摄取半衰期(分别增至145±18%和649±121%)。当(+)-WAY 100135与摄取阻滞剂联合添加时,帕罗西汀对刺激诱发的5-HT外流的作用增强至282±48%(P<0.01),而对5-HT再摄取半衰期无进一步影响。4. 通过放射性配体结合和[35S]-GTPγS结合测定了(+)-WAY 100135在CHO细胞中表达的重组人5-HT1B和5-HT1D受体上的亲和力和内在活性。(+)-WAY 100135是一种人5-HT1B和5-HT1D受体的部分激动剂,对5-HT1D受体具有中等高度的亲和力(pEC50 = 7.61)。5. 总之,发现(+)-WAY 100135并非选择性5-HT1A自身受体拮抗剂,而是可能作为5-HT1B/1D受体的部分激动剂,根据所采用的刺激方案和受体处产生的5-HT“张力”表现出激动剂或拮抗剂特性。

相似文献

1
(+)-WAY 100135, a partial agonist, at native and recombinant 5-HT1B/1D receptors.(+)-WAY 100135,一种部分激动剂,作用于天然和重组5-HT1B/1D受体。
Br J Pharmacol. 1997 Jun;121(4):737-42. doi: 10.1038/sj.bjp.0701197.
2
SB-224289--a novel selective (human) 5-HT1B receptor antagonist with negative intrinsic activity.SB - 224289——一种新型的具有负性内在活性的选择性(人)5 - 羟色胺1B受体拮抗剂。
Br J Pharmacol. 1998 Sep;125(1):202-8. doi: 10.1038/sj.bjp.0702059.
3
Modulation by 5-HT1A receptors of the 5-HT2 receptor-mediated tachykinin-induced contraction of the rat trachea in vitro.5-羟色胺1A受体对5-羟色胺2受体介导的速激肽诱导的大鼠气管体外收缩的调节作用
Br J Pharmacol. 1998 Apr;123(8):1571-8. doi: 10.1038/sj.bjp.0701771.
4
Serotonin efflux in the rat ventral lateral geniculate nucleus assessed by fast cyclic voltammetry is modulated by 5-HT1B and 5-HT1D autoreceptors.通过快速循环伏安法评估的大鼠腹侧外侧膝状核中的5-羟色胺流出受5-HT1B和5-HT1D自身受体调节。
Neuropharmacology. 1996;35(11):1627-34. doi: 10.1016/s0028-3908(96)00081-0.
5
SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2'methyl-4'-(5-methyl-1,2,3-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): a novel, potent and selective 5-HT1B receptor antagonist.SB - 616234 - A(1 - [6 - (顺式 - 3,5 - 二甲基哌嗪 - 1 - 基) - 2,3 - 二氢 - 5 - 甲氧基吲哚 - 1 - 基] - 1 - [2' - 甲基 - 4' - (5 - 甲基 - 1,2,3 - 恶二唑 - 3 - 基)联苯 - 4 - 基]甲酮盐酸盐):一种新型、强效且选择性的5 - HT1B受体拮抗剂。
Neuropharmacology. 2006 Jun;50(8):984-90. doi: 10.1016/j.neuropharm.2006.01.008. Epub 2006 Mar 20.
6
WAY-163909 [(7bR, 10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole], a novel 5-hydroxytryptamine 2C receptor-selective agonist with anorectic activity.WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,10a-八氢-7bH-环戊并-[b][1,4]二氮杂卓并[6,7,1hi]吲哚],一种具有食欲抑制活性的新型5-羟色胺2C受体选择性激动剂。
J Pharmacol Exp Ther. 2005 May;313(2):862-9. doi: 10.1124/jpet.104.075382. Epub 2005 Feb 10.
7
Autoradiographic characterisation of [35S]GTPgammaS binding stimulation mediated by 5-HT1B receptor in postmortem human brain.5-羟色胺1B受体介导的死后人类大脑中[35S]GTPγS结合刺激的放射自显影表征
Neuropharmacology. 2005 Jan;48(1):25-33. doi: 10.1016/j.neuropharm.2004.08.013.
8
In vitro profile of the antidepressant candidate OPC-14523 at rat and human 5-HT1A receptors.抗抑郁候选药物OPC-14523对大鼠和人类5-羟色胺1A受体的体外研究概况
Eur J Pharmacol. 2005 Jul 11;517(3):165-73. doi: 10.1016/j.ejphar.2005.05.035.
9
S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: I. Interaction with cloned human (h)5-HT1A, dopamine hD2/hD3 and h alpha2A-adrenergic receptors in relation to modulation of cortical monoamine release and activity in models of potential antidepressant activity.S 15535,一种新型的5-羟色胺(5-HT)1A受体苯并二氧哌嗪配体:I. 与克隆的人(h)5-HT1A、多巴胺hD2/hD3和hα2A - 肾上腺素能受体的相互作用及其对皮质单胺释放和潜在抗抑郁活性模型中活性的调节作用。
J Pharmacol Exp Ther. 1997 Jul;282(1):132-47.
10
SB-649915, a novel, potent 5-HT1A and 5-HT1B autoreceptor antagonist and 5-HT re-uptake inhibitor in native tissue.SB-649915,一种新型、强效的5-羟色胺1A和5-羟色胺1B自身受体拮抗剂,也是天然组织中的5-羟色胺再摄取抑制剂。
Eur J Pharmacol. 2006 Apr 24;536(1-2):54-61. doi: 10.1016/j.ejphar.2006.02.042. Epub 2006 Feb 28.

引用本文的文献

1
Separable gain control of ongoing and evoked activity in the visual cortex by serotonergic input. 视觉皮层中血清素能传入对持续活动和诱发活动的可分离增益控制。
Elife. 2020 Apr 7;9:e53552. doi: 10.7554/eLife.53552.
2
Environment Influencing Serotonin Syndrome Induced by Ecstasy Abuse.环境对摇头丸滥用所致血清素综合征的影响
Ann Forensic Res Anal. 2017;4(1). Epub 2017 Mar 7.
3
MDMA modulates spontaneous firing of subthalamic nucleus neurons in vitro.摇头丸在体外调节丘脑底核神经元的自发放电。
Exp Brain Res. 2015 Jan;233(1):137-47. doi: 10.1007/s00221-014-4095-6. Epub 2014 Sep 19.
4
Modulation of 5-HT7 receptor: effect on object recognition performances in mice.5-羟色胺7受体的调节:对小鼠物体识别能力的影响。
Psychopharmacology (Berl). 2014 Jan;231(2):393-400. doi: 10.1007/s00213-013-3247-x. Epub 2013 Aug 31.
5
Pharmacological diversity between native human 5-HT1B and 5-HT1D receptors sited on different neurons and involved in different functions.位于不同神经元上且参与不同功能的天然人类5-HT1B和5-HT1D受体之间的药理学差异。
Br J Pharmacol. 1999 Feb;126(3):607-12. doi: 10.1038/sj.bjp.0702336.